An association study between catechol-O-methyl transferase gene polymorphism and methamphetamine psychotic disorder

Atsuko Suzuki, Kazuhiko Nakamura, Yoshimoto Sekine, Yoshio Minabe, Nori Takei, Katsuaki Suzuki, Yasuhide Iwata, Masayoshi Kawai, Kiyokazu Takebayashi, Hideo Matsuzaki, Masaomi Iyo, Norio Ozaki, Toshiya Inada, Nakao Iwata, Mutsuo Harano, Tokutaro Komiyama, Mitsuhiko Yamada, Ichiro Sora, Hiroshi Ujike, Norio Mori

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

OBJECTIVE: A series of methamphetamine psychosis reveals two kinds of clinical courses of methamphetamine psychosis: transient type and prolonged type. Furthermore, paranoid psychosis sometimes recurs without methamphetamine reuse, referred to as spontaneous relapse. Dysfunction of central dopaminergic neurotransmission has been implicated in the pathogenesis of these psychiatric states. Catechol-O-methyl transferase appears to play a unique role in regulating synaptic dopaminergic activity. This study aimed to investigate whether a functional polymorphism of the catechol-O-methyl transferase gene would be involved in the development of these psychiatric states. BASIC METHODS: We examined the functional polymorphism of val 158 met (catechol-O-methyl transferase) in 143 patients with methamphetamine psychosis and 200 healthy controls in Japan. The patients were divided into subgroups by several characteristic clinical features. MAIN RESULTS: We found a significant difference in the catechol-O-methyl transferase allele frequency between patients with spontaneous relapse and the controls (P=0.018, odds ratio=1.67). Odds ratio implied that the patients with spontaneous relapse had a nearly 1.7-fold higher rate of the low activity alleles (met) than the controls. CONCLUSIONS: Our results indicate that the met allele frequency of the catechol-O-methyl transferase is associated with patients who experienced methamphetamine psychosis and spontaneous relapse, suggesting that patients with a met allele appear to be at increased risk of an adverse response to methamphetamine.

Original languageEnglish
Pages (from-to)133-138
Number of pages6
JournalPsychiatric Genetics
Volume16
Issue number4
DOIs
Publication statusPublished - 01-08-2006

Fingerprint

Guaiacol
Methamphetamine
Transferases
Psychotic Disorders
Genes
Recurrence
Gene Frequency
Psychiatry
Alleles
Odds Ratio
Paranoid Disorders
Synaptic Transmission
Japan

All Science Journal Classification (ASJC) codes

  • Genetics
  • Genetics(clinical)
  • Psychiatry and Mental health
  • Biological Psychiatry

Cite this

Suzuki, Atsuko ; Nakamura, Kazuhiko ; Sekine, Yoshimoto ; Minabe, Yoshio ; Takei, Nori ; Suzuki, Katsuaki ; Iwata, Yasuhide ; Kawai, Masayoshi ; Takebayashi, Kiyokazu ; Matsuzaki, Hideo ; Iyo, Masaomi ; Ozaki, Norio ; Inada, Toshiya ; Iwata, Nakao ; Harano, Mutsuo ; Komiyama, Tokutaro ; Yamada, Mitsuhiko ; Sora, Ichiro ; Ujike, Hiroshi ; Mori, Norio. / An association study between catechol-O-methyl transferase gene polymorphism and methamphetamine psychotic disorder. In: Psychiatric Genetics. 2006 ; Vol. 16, No. 4. pp. 133-138.
@article{ead796d0b1a643179c9d18b56dcdcab0,
title = "An association study between catechol-O-methyl transferase gene polymorphism and methamphetamine psychotic disorder",
abstract = "OBJECTIVE: A series of methamphetamine psychosis reveals two kinds of clinical courses of methamphetamine psychosis: transient type and prolonged type. Furthermore, paranoid psychosis sometimes recurs without methamphetamine reuse, referred to as spontaneous relapse. Dysfunction of central dopaminergic neurotransmission has been implicated in the pathogenesis of these psychiatric states. Catechol-O-methyl transferase appears to play a unique role in regulating synaptic dopaminergic activity. This study aimed to investigate whether a functional polymorphism of the catechol-O-methyl transferase gene would be involved in the development of these psychiatric states. BASIC METHODS: We examined the functional polymorphism of val 158 met (catechol-O-methyl transferase) in 143 patients with methamphetamine psychosis and 200 healthy controls in Japan. The patients were divided into subgroups by several characteristic clinical features. MAIN RESULTS: We found a significant difference in the catechol-O-methyl transferase allele frequency between patients with spontaneous relapse and the controls (P=0.018, odds ratio=1.67). Odds ratio implied that the patients with spontaneous relapse had a nearly 1.7-fold higher rate of the low activity alleles (met) than the controls. CONCLUSIONS: Our results indicate that the met allele frequency of the catechol-O-methyl transferase is associated with patients who experienced methamphetamine psychosis and spontaneous relapse, suggesting that patients with a met allele appear to be at increased risk of an adverse response to methamphetamine.",
author = "Atsuko Suzuki and Kazuhiko Nakamura and Yoshimoto Sekine and Yoshio Minabe and Nori Takei and Katsuaki Suzuki and Yasuhide Iwata and Masayoshi Kawai and Kiyokazu Takebayashi and Hideo Matsuzaki and Masaomi Iyo and Norio Ozaki and Toshiya Inada and Nakao Iwata and Mutsuo Harano and Tokutaro Komiyama and Mitsuhiko Yamada and Ichiro Sora and Hiroshi Ujike and Norio Mori",
year = "2006",
month = "8",
day = "1",
doi = "10.1097/01.ypg.0000218613.35139.cd",
language = "English",
volume = "16",
pages = "133--138",
journal = "Psychiatric Genetics",
issn = "0955-8829",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

Suzuki, A, Nakamura, K, Sekine, Y, Minabe, Y, Takei, N, Suzuki, K, Iwata, Y, Kawai, M, Takebayashi, K, Matsuzaki, H, Iyo, M, Ozaki, N, Inada, T, Iwata, N, Harano, M, Komiyama, T, Yamada, M, Sora, I, Ujike, H & Mori, N 2006, 'An association study between catechol-O-methyl transferase gene polymorphism and methamphetamine psychotic disorder', Psychiatric Genetics, vol. 16, no. 4, pp. 133-138. https://doi.org/10.1097/01.ypg.0000218613.35139.cd

An association study between catechol-O-methyl transferase gene polymorphism and methamphetamine psychotic disorder. / Suzuki, Atsuko; Nakamura, Kazuhiko; Sekine, Yoshimoto; Minabe, Yoshio; Takei, Nori; Suzuki, Katsuaki; Iwata, Yasuhide; Kawai, Masayoshi; Takebayashi, Kiyokazu; Matsuzaki, Hideo; Iyo, Masaomi; Ozaki, Norio; Inada, Toshiya; Iwata, Nakao; Harano, Mutsuo; Komiyama, Tokutaro; Yamada, Mitsuhiko; Sora, Ichiro; Ujike, Hiroshi; Mori, Norio.

In: Psychiatric Genetics, Vol. 16, No. 4, 01.08.2006, p. 133-138.

Research output: Contribution to journalArticle

TY - JOUR

T1 - An association study between catechol-O-methyl transferase gene polymorphism and methamphetamine psychotic disorder

AU - Suzuki, Atsuko

AU - Nakamura, Kazuhiko

AU - Sekine, Yoshimoto

AU - Minabe, Yoshio

AU - Takei, Nori

AU - Suzuki, Katsuaki

AU - Iwata, Yasuhide

AU - Kawai, Masayoshi

AU - Takebayashi, Kiyokazu

AU - Matsuzaki, Hideo

AU - Iyo, Masaomi

AU - Ozaki, Norio

AU - Inada, Toshiya

AU - Iwata, Nakao

AU - Harano, Mutsuo

AU - Komiyama, Tokutaro

AU - Yamada, Mitsuhiko

AU - Sora, Ichiro

AU - Ujike, Hiroshi

AU - Mori, Norio

PY - 2006/8/1

Y1 - 2006/8/1

N2 - OBJECTIVE: A series of methamphetamine psychosis reveals two kinds of clinical courses of methamphetamine psychosis: transient type and prolonged type. Furthermore, paranoid psychosis sometimes recurs without methamphetamine reuse, referred to as spontaneous relapse. Dysfunction of central dopaminergic neurotransmission has been implicated in the pathogenesis of these psychiatric states. Catechol-O-methyl transferase appears to play a unique role in regulating synaptic dopaminergic activity. This study aimed to investigate whether a functional polymorphism of the catechol-O-methyl transferase gene would be involved in the development of these psychiatric states. BASIC METHODS: We examined the functional polymorphism of val 158 met (catechol-O-methyl transferase) in 143 patients with methamphetamine psychosis and 200 healthy controls in Japan. The patients were divided into subgroups by several characteristic clinical features. MAIN RESULTS: We found a significant difference in the catechol-O-methyl transferase allele frequency between patients with spontaneous relapse and the controls (P=0.018, odds ratio=1.67). Odds ratio implied that the patients with spontaneous relapse had a nearly 1.7-fold higher rate of the low activity alleles (met) than the controls. CONCLUSIONS: Our results indicate that the met allele frequency of the catechol-O-methyl transferase is associated with patients who experienced methamphetamine psychosis and spontaneous relapse, suggesting that patients with a met allele appear to be at increased risk of an adverse response to methamphetamine.

AB - OBJECTIVE: A series of methamphetamine psychosis reveals two kinds of clinical courses of methamphetamine psychosis: transient type and prolonged type. Furthermore, paranoid psychosis sometimes recurs without methamphetamine reuse, referred to as spontaneous relapse. Dysfunction of central dopaminergic neurotransmission has been implicated in the pathogenesis of these psychiatric states. Catechol-O-methyl transferase appears to play a unique role in regulating synaptic dopaminergic activity. This study aimed to investigate whether a functional polymorphism of the catechol-O-methyl transferase gene would be involved in the development of these psychiatric states. BASIC METHODS: We examined the functional polymorphism of val 158 met (catechol-O-methyl transferase) in 143 patients with methamphetamine psychosis and 200 healthy controls in Japan. The patients were divided into subgroups by several characteristic clinical features. MAIN RESULTS: We found a significant difference in the catechol-O-methyl transferase allele frequency between patients with spontaneous relapse and the controls (P=0.018, odds ratio=1.67). Odds ratio implied that the patients with spontaneous relapse had a nearly 1.7-fold higher rate of the low activity alleles (met) than the controls. CONCLUSIONS: Our results indicate that the met allele frequency of the catechol-O-methyl transferase is associated with patients who experienced methamphetamine psychosis and spontaneous relapse, suggesting that patients with a met allele appear to be at increased risk of an adverse response to methamphetamine.

UR - http://www.scopus.com/inward/record.url?scp=33748436265&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748436265&partnerID=8YFLogxK

U2 - 10.1097/01.ypg.0000218613.35139.cd

DO - 10.1097/01.ypg.0000218613.35139.cd

M3 - Article

C2 - 16829779

AN - SCOPUS:33748436265

VL - 16

SP - 133

EP - 138

JO - Psychiatric Genetics

JF - Psychiatric Genetics

SN - 0955-8829

IS - 4

ER -